ICSSUi002-A
General
Cell Line |
|
hPSCreg name | ICSSUi002-A |
Cite as: | ICSSUi002-A (RRID:CVCL_B5IM) |
Cell line type | Human induced pluripotent stem cell (hiPSC) |
Similar lines |
|
Last update | 15th April 2022 |
User feedback | |
Provider |
|
Generator | Institute for Cardiovascular Science of Soochow University (ICSSU) |
External Databases |
|
Cellosaurus | CVCL_B5IM |
BioSamples | SAMEA13061469 |
Wikidata | Q110432918 |
General Information |
|
Publications |
|
* Is the cell line readily obtainable for third parties? |
Yes Research use: allowed
Clinical use: not allowed
Commercial use: not allowed
|
Donor Information
General Donor Information |
|
Sex | male |
Ethnicity | Han-chinese |
Phenotype and Disease related information (Donor) |
|
Diseases | A disease was diagnosed.
|
Family history | No |
Karyotyping (Donor) |
|
Has the donor karyotype been analysed? |
No
|
External Databases (Donor) |
|
BioSamples | SAMEA13061470 |
Ethics
Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived? | Yes |
Was the consent voluntarily given? | Yes |
Has the donor been informed that participation will not directly influence their personal treatment? | Yes |
Can you provide us with a copy of the Donor Information Sheet provided to the donor? | Yes |
Do you (Depositor/Provider) hold the original Donor Consent Form? | Yes |
Alternatives to consent are available? | No |
Is there other documentation provided to the donor for consenting purposes? | No |
Please indicate whether the data associated with the donated material has been pseudonymised or anonymised. | anonymised |
Does consent explicitly allow the derivation of pluripotent stem cells? | Yes |
Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world? | Yes |
How may genetic information associated with the cell line be accessed? | Controlled Access |
Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample? | No |
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? | Yes |
Name of accrediting authority involved? | Ethics Committee of First Affiliated Hospital of Soochow University |
Approval number | No. 2019-359 |
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used? |
hIPSC Derivation
General |
|
Source cell type |
A peripheral blood cell with a single nucleus. This category includes lymphocytes and monocytes.
Synonyms
|
Reprogramming method |
|
Vector type | Non-integrating |
Vector | Episomal |
Vector free reprogramming |
|
Other |
|
Derived under xeno-free conditions |
Unknown |
Derived under GMP? |
Unknown |
Available as clinical grade? |
Unknown |
Culture Conditions
Surface coating | Matrigel/Geltrex |
Feeder cells |
No |
Passage method |
Enzyme-free cell dissociation
EDTA
|
O2 Concentration | 21 % |
CO2 Concentration | 5 % |
Medium |
mTeSR™ 1
|
Has Rock inhibitor (Y27632) been used at passage previously with this cell line? | Yes |
Has Rock inhibitor (Y27632) been used at cryo previously with this cell line? | No |
Has Rock inhibitor (Y27632) been used at thaw previously with this cell line? | Yes |
Characterisation
Analysis of Undifferentiated Cells
Marker | Expressed | Immunostaining | RT-PCR | Flow Cytometry | Enzymatic Assay | Expression Profiles |
NANOG |
Yes |
|||||
TRA 1-60 |
Yes |
|
||||
SSEA-4 |
Yes |
|||||
POU5F1 (OCT-4) |
Yes |
Differentiation Potency
In vivo teratoma
In vitro spontaneous differentiation
Marker | Expressed |
FOXA2 |
Yes |
SOX17 |
Yes |
In vivo teratoma
In vitro spontaneous differentiation
Marker | Expressed |
TBXT |
Yes |
EOMES |
Yes |
In vivo teratoma
In vitro spontaneous differentiation
Marker | Expressed |
SOX1 |
Yes |
PAX6 |
Yes |
Genotyping
Karyotyping (Cell Line) |
|
Has the cell line karyotype been analysed? |
Yes
|
Other Genotyping (Cell Line) |
Login to share your feedback, experiences or results with the research community.